- Journal List
- Med Gas Res
- v.11(1); Jan-Mar 2021
- PMC8103971
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsem*nt of, or agreement with, the contents by NLM or the National Institutes of Health.
Learn more: PMC Disclaimer | PMC Copyright Notice
Med Gas Res. 2021 Jan-Mar; 11(1): 30–33.
Published online 2021 Feb 26. doi:10.4103/2045-9912.310057
PMCID: PMC8103971
PMID: 33642335
Suman Sen, MDS1,* and Sheuli Sen2
Author information Article notes Copyright and License information PMC Disclaimer
Abstract
Hyperbaric oxygen therapy refers to inhalation of pure oxygen in a closed chamber. Hyperbaric oxygen has a therapeutic effect in numerous pathological conditions, such as decompression sickness, arterial gas embolism, carbon monoxide poisoning and smoke inhalation, osteomylitis, osteoradionecrosis and wound healing. Hyperbaric oxygen therapy is used for treating underlying hypoxia. This review indicates the action of hyperbaric oxygen on biochemical and various physiological changes in cellular level. Narrative review covers the current indications and contraindications of hyperbaric oxygen therapy. The review also focuses on the therapeutic effects of hyperbaric oxygen pretreatment and precondition in different pathological conditions. The complications and side effects of hyperbaric oxygen therapy are discussed.
Keywords: carbon monoxide poisoning, decompression sickness, hyperbaric oxygen therapy, osteomylitis, osteoradionecrosis, wound healing
INTRODUCTION
The prefix “hyper” means increased while “baric” refers to pressure. During hyperbaric oxygen therapy (HBOT) a patient inhales 100% pure oxygen greater than normal atmospheric pressure inside a highly pressured chamber. Inside this chamber, the oxygen pressure is usually 1.5–3 times than that at sea level. In 1620, Drebbel developed a one-atmosphere diving bell.1 Use of hyperbaric therapy was first documented in 1662. Nathaniel Henshaw, a British clergy and physician, used a system of organ bellows with unidirectional valves to change the atmospheric pressure in a sealed air tight chamber called domicilium in which oxygen is compressed and decompressed. In 1937, Behnke and Shaw for the first time used hyperbaric chamber in treating patients with decompression sickness. Since 1955, HBOT has been used for the management of various medical conditions.2
Oxygen (O2) transportation in blood is mainly by hemoglobin that has an oxygen saturation of about 97% while plasma contains 0.32% of dissolved oxygen under normal atmospheric pressure.3 The blood circulation helps to delivery of oxygen and other nutrients to the tissues and to remove the products of metabolism including carbon dioxide.4 Oxygen delivery is dependent on oxygen availability, the ability of arterial blood to transport oxygen and tissue perfusion.5 Normal concentration of oxygen in blood at sea level is 3 mL/L. Tissues of a healthy individual during rest need around 60 mL of oxygen per 1 L of blood flow that helps in metabolism of cells. At atmospheric pressure of 304 kPa dissolved oxygen approaches 60 mL/L plasma, that is the total oxygen needed by tissues at rest.6 During the HBOT procedure, the oxygen pressure in arterial blood can increase to 2000 mmHg (~266.6 kPa), and the high blood-to-tissue oxygen pressure gradient increases the tissue oxygen pressure to 500 mmHg (~66.7 kPa).7 This has a positive effect on the healing of inflammatory and microcirculatory disorders under ischemic conditions.
In the HBOT the individual is placed in a closed chamber and breathes pure oxygen. The oxygen pressure inside the chamber and the duration are increased depending on individual pathological conditions. The HBOT duration varies from 3 minutes to 2 hours till the pressure inside the chamber becomes normal. There may be little discomfort and ear pain during the alteration of oxygen pressure inside the chamber.6
MECHANISMS UNDERLYING THE THERAPEUTIC EFFECTS
At cellular level around 80% of oxygen is utilized by mitochondria which is a power house of cells while remaining 20% is used by other organelles. Mitochondria require oxygen to receive the electrons at the end of the electron transport chain to utilize that energy to make adenosine triphosphate. Hypoxia leads to increase the oxidative stress that results in generation of reactive free radicals of oxygen and nitrogen.8 Free radicals of oxygen and nitrogen are extremely toxic to cells and result in damage which induces cellular death and apoptosis.9 The HBOT helps to correct hypoxic condition by increasing oxygen delivery leading antimicrobial activity and the attenuation of the hypoxia-inducible factor mediated effects. Its effects also reduce the formation of reduce oxidative stress, increasing the body’s ability to heal, vasoconstriction, and angiogenesis resulting in reduced inflammation.10 Hyperbaric oxygen dissociates carbon monoxide from cytochrome C oxidase, improving electron transport and cellular energy state.6 The therapeutic pressures used in HBOT are described in terms of atmospheres absolute pressure ranging from 1.5 to 3.0 atm (1 atm = 101.325 kPa). Biochemical changes in cellular level of HBOT are indicated in Table 1.
Table 1
Biochemical changes in cellular level of hyperbaric oxygen
| No. | Biochemical changes |
|---|---|
| 1 | Hyperbaric oxygen therapy helps in angiogenesis that promotes healing wounds |
| 2 | Increase oxygen content kills anaerobic bacteria |
| 3 | Prevent the production of clostridial α toxin and pseudomonas species |
| 4 | It helps to restore neutrophil mediated killing of bacteria |
| 5 | Reduce leucocyte adhesion in reperfusion injury |
| 6 | Prevent the release of free radicals and proteases which causes vasoconstriction and cellular damage |
Open in a separate window
INDICATIONS AND CONTRADICTIONS TO HYPERBARIC OXYGEN THERAPY
The therapeutic uses of HBOT in various pathologic conditions are included in Table 2.6,11,12,13Table 3 includes contraindication and limitations for the HBOT.6,11
Table 2
Therapeutic indications and uses of hyperbaric oxygen therapy
| No. | Therapeutic indication and uses |
|---|---|
| 1 | Refectory osteomyelitis – infection caused in bones |
| 2 | Management of osteoradionecrosis–complication during radiotherapy |
| 3 | Carbon monoxide poisoning and during inhalation of excessive smoke |
| 4 | Cyanide poisoning |
| 5 | Gas gangrene, gangrene where the gas accumulates in tissues |
| 6 | Decompression sickness during deep water diving |
| 7 | Injury from crushing where there is sudden inadequate blood flow in the arteries and in ischemic injury |
| 8 | Delayed wound healing and improved skin graft and flap healing |
| 9 | Necrotizing bacterial soft tissue infections |
| 10 | Gas embolism caused in blood vessels due to air bubble entrapment |
| 11 | Brain trauma, chronic stroke and acute cerebral edema |
| 12 | Delayed healing of diabetic wounds |
| 13 | Adjuvant treatment in anemia due to blood loss |
| 14 | Hemorrhagic shock |
| 15 | Radiation induced injury |
| 16 | Infection caused due to clostridial myonecrosis and actinomycetes |
| 17 | Neuroblastoma stage IV |
| 18 | Post anorexia encephalopathy |
| 19 | Sudden deafness |
| 20 | Limb replantation, skin graft and flaps |
| 21 | Aggressive periodontitis |
| 22 | Pneumatosis cystoides intestinalis |
Open in a separate window
Table 3
Contraindications of hyperbaric oxygen therapy
| No. | Contraindications and limitations |
|---|---|
| 1 | In lung conditions where there are chances of lung collapse |
| 2 | Ear injury and thoracic surgery |
| 3 | Upper respiratory tract infection |
| 4 | Pregnancy |
| 5 | Pneumothorax |
| 6 | Uncontrolled hypothermia |
| 7 | In claustrophobia individuals |
Open in a separate window
During prolonged duration of HBOT oxygen poisoning can be prevented by giving short breaks and breathing normal air. This will lead to lessen the excessive oxygen taken by the tissues. During HBOT each individual will be given specific dose depending on their age, pathologic condition and the site of the disease to minimize the chance of toxicity and complications. The most common symptoms during HBOT include light headache and fatigue which are reversible as the individual are taken out of the hyperbaric oxygen chamber. The side effects of the HBOT are relatively less when the individual is placed less than 2 hours inside the chamber and when the pressure does not exceed 300 kPa compared to normal atmospheric pressure. Though the side effect is mild but can be life-threatening if not managed immediately. The common side effects that may be encountered are nausea, vomiting, myopia, feeling of claustrophobia, fatigue and headache. Table 4 includes the complications and side effects that can be associated with HBOT.
Table 4
Complications associated with hyperbaric oxygen therapy
| No. | Complications and side effects |
|---|---|
| 1 | It can cause severe damage to lungs by altering lung capacity leading to subcutaneous emphysema, intrapulmonary hemorrhage |
| 2 | Barotrauma of the ear due to increased air pressure in the middle-ear cannot be equalized with the external pressure, the eardrum will bow inward, leading to pain and possibly rupture, leading to hearing loss |
| 3 | Excessive fluid buildup can rupture the middle ear |
| 4 | Can cause sinus pathology as barosinusitis can lead to epistaxis |
| 5 | Changes in vision, causing myopia |
| 6 | Barodontalgia/odontocrexis (pain in a tooth caused by a change in atmospheric pressure) |
| 7 | Accumulation of fluids inside lungs |
| 8 | Change in brain electrical activity may cause seizures |
Open in a separate window
CLINICAL APPLICATION AS THERAPEUTIC USES OF HYPERBARIC OXYGEN
Necrotizing infections
Soft infections caused by clostridial α toxin production leads to myonecrosis and gas gangrene. Experimental evidence and clinical experience suggest that treatment with hyperbaric oxygen improves systemic illness and decreases tissue loss by demarcating the border between devitalized and healthy tissue. This reduces the extent of surgical amputation or debridement.14 In necrotizing fasciitis studies suggest that hyperbaric oxygen plays an adjuvant role with surgical debridement. It enhances blood perfusion and improves innate immunity at the site of injury.15
Osteomyelitis
Osteomyelitis is an infection of bone. Bacteria present in the bloodstream from infectious diseases spreads to the bone. HBOT also has a beneficial role in refectory osteomylitis.16 Osteomyelitis treatments mainly include extensive irrigation and debridement, intravenous antibiotics, and reconstruction. HBOT helps osteogenesis, neovascularization, and collagen production.17,18,19 HBOT increases the oxygen tension in ischemic wounds under conditions of adequate arterial inflow. This effect of HBOT on tissue oxygenation is obtained through formation of new vessels by neovascularization and increase in vascular endothelial growth factor.20,21 Therapeutic effects of HBOT on infections can be made by direct suppression the growth of anaerobic bacteria such as clostridia and hyperoxygenation in tissues causes increase the fibroblasts and collagen proliferation, neovascularization of ischemic tissues and stimulation of bacterial lysis by leukocytes.22,23 After surgical debridement of the osteolytic region, HBO at 2.4 to 2.5 atmospheres absolute pressure (ATA; 1 ATA = 101.325 kPa) for 5 to 7 times per week provides clinical efficacy by removing swelling and pain. A total of 30 to 40 treatments are required to get the clinical results.
Carbon monoxide poisoning
Carbon monoxide has 200 times more binding capacity to hemoglobin in blood than oxygen thus reducing the oxygen content in blood. Hemoglobin sites that are free from binding have an increased affinity towards oxygen, and this reduces the availability of oxygen to the tissues leading to hypoxia. Hyperbaric oxygen gives an alternative source of tissue oxygenation through oxygen dissolved in the plasma.24 HBOT acts by dissociation of carbon monoxide from the hemoglobin and myoglobin.25 The symptoms associated with carbon monoxide poising are loss of consciousness, neurological abnormalities, myocardial ischemia, pulmonary edema, metabolic acidosis, headache and delayed neurological features that may became permanent if not treated at an early stage. At 2–3 ATA for 60–90 minutes breathing 100% oxygen helps to treat this condition.26
Decompression sickness and arterial gas embolism
Decompression sickness caused due to sudden alteration in atmospheric pressure is commonly noted in scuba divers, aviators and deep tunnel workers as there is a change in atmospheric pressure when they leave that environment. Delay in treating decompression sickness with hydration and HBOT can result in permanent symptoms and even death.27 After deep water diving when the divers surface rapidly at sea level attitude the partial pressure of nitrogen dissolved in the tissues exceed the ambient atmospheric pressure to form air bubbles in the blood and tissues.28 Even at an altitude of over 5500 m decompression sickness can occur. In air embolism the air can enter the blood circulation during the placement of catheters in arteries and veins, cardiothoracic surgery, hemodialysis. Decompression sickness can cause skin rashes, joint pain, paralysis, confusion, convulsions, difficulty in speech, visual disturbances, and balance disturbance; sensory loss bladder dysfunction, sphincter dysfunction; loss of coordination in the limbs; shortness of breath, which may lead to death secondary to blockage of vital blood vessels by air emboli. Hyperbaric oxygen recompression given at a pressure of 250–300 kPa for 2–5 hours relives the symptoms.
Osteoradionecrosis
Osteoradionecrosis (ORN) is noted when the bone exposed to radiation undergoes necrosis and becomes exposed under soft-tissue. ORN occur commonly after radiotherapy in head and neck carcinoma.29 It commonly affects the mandible in orofacial region. ORN results in irreversible tissue death, which is seen as exposed bone for more than 3 months duration.30 ORN can occur between an interval of 4 months to 2 years after radiotherapy.31 In ORN through ulcerated mucosa exposed bone seen that causes severe pain, dysesthesia, halitosis, dysgeusia and food lodgment. In ORN initially there is suppression of osteoclast related bone turnover.32,33 Radiotherapy causes hypoxia in tissues and hypocellularity resulting in tissue breakdown and chronic non-healing wounds. HBOT increases the oxygen concentration by correcting the hypoxia and cell regeneration. Around 30 preoperative and 10 postoperative HBO sessions for 90 minutes are recommended to prevent mandibular osteonecrosis after surgery on irradiated facial and neck tissue.6
Skin grafts, flaps, and wound healing
HBOT is beneficial and useful in wound healing process. It can also have therapeutic importance in wounds from burns and diabetic ulcers.34,35,36 It has a positive role in compromised flaps and can increase the effective size of composite graft survival, and improve prognosis of flap survival. Generally the skin grafts contain different tissue types with varying sizes that lack proper blood supply and are depended on the host for nutrient. HBOT acts by increasing oxygenation in the blood vessels and tissues by improving fibroblast function, collagen synthesis and neovascularization that helps in wound healing. HBO, given at a pressures of 2.0–2.5 ATA for duration of 90–120 minutes twice daily, helps in complete saturation of hemoglobin with oxygen in the circulation, along with a 10-fold increase in the dissolved oxygen plasma level.37
Brain stroke
HBOT also helps in treatment of brain trauma and acute cerebral edema mostly associated with chronic stages of strokes causing memory and speech loss.38 HBOT induces angiogenesis and the recruitment of progenitor cells to the damaged regions.39 Cell death is the focus of HBOT treatment, as it reduces the inflammatory cytokine level that is associated with limiting peri-infarct tissue loss.40 Hyperbaric oxygen suppresses the increased circulating macrophages in the acute phase and accelerated macrophage invasion into the contused muscle. This helps to increase the number of proliferating and differentiating satellite cells and the amount of regenerated muscle fibers.
HYPERBARIC OXYGEN PRE-CONDITIONING
Hyperbaric oxygen exposure before few procedures that create a preventive therapeutic situation is called as “preconditioning.” Hyperbaric oxygen pre-conditioning has a beneficial effect in diving, ischemic and inflammatory conditions. Oxygen pre-breathing causes reduced post-diving bubble leading to reduced decompression requirements and more rapid return to normal platelet function after a decompression. During the reperfusion of ischemic tissue, oxygenated blood increases numbers and activities of oxidants generated in tissues. Hyperbaric oxygen pre-conditioning causes the activation of antioxidative enzymes in the central nervous system, including catalase, superoxide dismutase and heme oxygenase-1.41 Hyperbaric oxygen pre-conditioning also protects against focal cerebral ischemia and traumatic brain injury. Hyperbaric oxygen preconditioning has cerebral-protective and cardiac-protective effects.42 Hyperbaric oxygen pre-conditioning attenuates brain edema, microglia activation, and inflammation after intracerebral hemorrhage.
CONCLUSION
Hyperbaric therapy utilizes high pressure oxygen response. It elevates the concentration of oxygen in hemoglobin and plasma. Based on its solubility under pressure increases the diffusion gradient for its delivery deeper into tissues, which is the main mechanism of HBOT. Ultimately the increases in dissolved oxygen generated by hyperbaric therapy have several physiologic effects that can change tissue responses to numerous physiological changes. Long term studies should be conducted to see its outcome in different therapeutic treatment regimens along with its complications and side effects that required obtaining the clinical and cost effective results.
Footnotes
Conflicts of interest
None declared.
Financial support
None.
Copyright license agreement
The Copyright License Agreement has been signed by both authors before publication.
Plagiarism check
Checked twice by iThenticate.
Peer review
Externally peer reviewed.
REFERENCES
1. Neubauer RA, Maxfield WS. The polemics of hyperbaric medicine. J Am Phys Surg. 2005;10:1. [Google Scholar]
2. Sharkey S. Current indications for hyperbaric oxygen therapy. J Aust Def Health Serv. 2000;1:64–72. [Google Scholar]
3. Daruwalla J, Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J Surg. 2006;30:2112–2131. [PubMed] [Google Scholar]
4. Ganong WF. Review of Medical Physiology. 21st ed. McGraw Hill; 2003. [Google Scholar]
5. Collins JA, Rudenski A, Gibson J, Howard L, O’Driscoll R. Relating oxygen partial pressure, saturation and content: the haemoglobin-oxygen dissociation curve. Breathe (Sheff) 2015;11:194–201. [PMC free article] [PubMed] [Google Scholar]
6. Leach RM, Rees PJ, Wilmshurst P. Hyperbaric oxygen therapy. BMJ. 1998;317:1140–1143. [PMC free article] [PubMed] [Google Scholar]
7. Bitterman H. Bench-to-bedside review: oxygen as a drug. Crit Care. 2009;13:205. [PMC free article] [PubMed] [Google Scholar]
8. Poyton RO, Ball KA, Castello PR. Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab. 2009;20:332–340. [PubMed] [Google Scholar]
9. Hoffman DL, Salter JD, Brookes PS. Response of mitochondrial reactive oxygen species generation to steady-state oxygen tension: implications for hypoxic cell signaling. Am J Physiol Heart Circ Physiol. 2007;292:H101–108. [PubMed] [Google Scholar]
10. Devaraj D, Srisakthi D. Hyperbaric oxygen therapy - can it be the new era in dentistry. J Clin Diagn Res? 2014;8:263–265. [PMC free article] [PubMed] [Google Scholar]
11. Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017;47:24–32. [PMC free article] [PubMed] [Google Scholar]
12. Bhutani S, Vishwanath G. Hyperbaric oxygen and wound healing. Indian J Plast Surg. 2012;45:316–324. [PMC free article] [PubMed] [Google Scholar]
13. Sahni T, Singh P, John MJ. Hyperbaric oxygen therapy: current trends and applications. J Assoc Physicians India. 2003;51:280–284. [PubMed] [Google Scholar]
14. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2004:CD004123. [PubMed] [Google Scholar]
15. Villanueva E, Bennett MH, Wasiak J, Lehm JP. Hyperbaric oxygen therapy for thermal burns. Cochrane Database Syst Rev. 2004:CD004727. [PMC free article] [PubMed] [Google Scholar]
16. Mendel V, Reichert B, Simanowski HJ, Scholz HC. Therapy with hyperbaric oxygen and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Undersea Hyperb Med. 1999;26:169–174. [PubMed] [Google Scholar]
17. Park MK, Muhvich KH, Myers RA, Marzella L. Hyperoxia prolongs the aminoglycoside-induced postantibiotic effect in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1991;35:691–695. [PMC free article] [PubMed] [Google Scholar]
18. Brismar K, Lind F, Kratz G. Dose-dependent hyperbaric oxygen stimulation of human fibroblast proliferation. Wound Repair Regen. 1997;5:147–150. [PubMed] [Google Scholar]
19. Marx RE, Ehler WJ, Tayapongsak P, Pierce LW. Relationship of oxygen dose to angiogenesis induction in irradiated tissue. Am J Surg. 1990;160:519–524. [PubMed] [Google Scholar]
20. Rollins MD, Gibson JJ, Hunt TK, Hopf HW. Wound oxygen levels during hyperbaric oxygen treatment in healing wounds. Undersea Hyperb Med. 2006;33:17–25. [PubMed] [Google Scholar]
21. Hopf HW, Kelly M, Shapshak D. Oxygen and the Basic Mechanisms of Wound Healing. In: Neuman T, Thom S, editors. Physiology and medicine of hyperbaric oxygen therapy. Philadelphia, PA, USA: Saunders Elsevier; 2008. pp. 203–228. [Google Scholar]
22. Kaide CG, Khandelwal S. Hyperbaric oxygen: applications in infectious disease. Emerg Med Clin North Am. 2008;26:571–595, xi. [PubMed] [Google Scholar]
23. Goerger E, Honnorat E, Savini H, et al. Anti-infective therapy without antimicrobials: Apparent successful treatment of multidrug resistant osteomyelitis with hyperbaric oxygen therapy. IDCases. 2016;6:60–64. [PMC free article] [PubMed] [Google Scholar]
24. Casillas S, Galindo A, Camarillo-Reyes LA, Varon J, Surani SR. Effectiveness of hyperbaric oxygenation versus normobaric oxygenation therapy in carbon monoxide poisoning: a systematic review. Cureus. 2019;11:e5916. [PMC free article] [PubMed] [Google Scholar]
25. Lettow I, Hoffmann A, Burmeister HP, Toepper R. Delayed neuropsychological sequelae after carbon monoxide poisoning. Fortschr Neurol Psychiatr. 2018;86:342–347. [PubMed] [Google Scholar]
26. Kuo SC, Hsu CK, Tsai CT, Chieh MJ. Hyperbaric oxygen therapy and acute carbon monoxide poisoning. Hu Li Za Zhi. 2018;65:11–17. [PubMed] [Google Scholar]
27. Zhang XC, Golden A, Bullard DS. Neurologic deep dive: a simulation case of diagnosing and treating decompression sickness for emergency medicine residents. MedEdPORTAL. 2016;12:10473. [PMC free article] [PubMed] [Google Scholar]
28. Benson J, Adkinson C, Collier R. Hyperbaric oxygen therapy of iatrogenic cerebral arterial gas embolism. Undersea Hyperb Med. 2003;30:117–126. [PubMed] [Google Scholar]
29. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004;62:527–534. [PubMed] [Google Scholar]
30. Kahenasa N, Sung EC, Nabili V, Kelly J, Garrett N, Nishimura I. Resolution of pain and complete healing of mandibular osteoradionecrosis using pentoxifylline and tocopherol: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:e18–23. [PubMed] [Google Scholar]
31. Rathy R, Sunil S, Nivia M. Osteoradionecrosis of mandible: Case report with review of literature. Contemp Clin Dent. 2013;4:251–253. [PMC free article] [PubMed] [Google Scholar]
32. Williamson RA. An experimental study of the use of hyperbaric oxygen to reduce the side effects of radiation treatment for malignant disease. Int J Oral Maxillofac Surg. 2007;36:533–540. [PubMed] [Google Scholar]
33. Bennett MH, Feldmeier J, Hampson NB, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2016;4:CD005005. [PMC free article] [PubMed] [Google Scholar]
34. Vinkel J, Holm NFR, Jakobsen JC, Hyldegaard O. Effects of adding adjunctive hyperbaric oxygen therapy to standard wound care for diabetic foot ulcers: a protocol for a systematic review with meta-analysis and trial sequential analysis. BMJ Open. 2020;10:e031708. [PMC free article] [PubMed] [Google Scholar]
35. Generaal JD, Lansdorp CA, Boonstra O, et al. Hyperbaric oxygen therapy for radiation-induced tissue injury following sarcoma treatment: A retrospective analysis of a Dutch cohort. PLoS One. 2020;15:e0234419. [PMC free article] [PubMed] [Google Scholar]
36. Liao J, Wu MJ, Mu YD, Li P, Go J. Impact of hyperbaric oxygen on tissue healing around dental implants in Beagles. Med Sci Monit. 2018;24:8150–8159. [PMC free article] [PubMed] [Google Scholar]
37. Francis A, Baynosa RC. Hyperbaric oxygen therapy for the compromised graft or flap. Adv Wound Care (New Rochelle) 2017;6:23–32. [PMC free article] [PubMed] [Google Scholar]
38. Gonzales-Portillo B, Lippert T, Nguyen H, Lee JY, Borlongan CV. Hyperbaric oxygen therapy: A new look on treating stroke and traumatic brain injury. Brain Circ. 2019;5:101–105. [PMC free article] [PubMed] [Google Scholar]
39. Zhai WW, Sun L, Yu ZQ, Chen G. Hyperbaric oxygen therapy in experimental and clinical stroke. Med Gas Res. 2016;6:111–118. [PMC free article] [PubMed] [Google Scholar]
40. Meng XE, Zhang Y, Li N, et al. Hyperbaric oxygen alleviates secondary brain injury after trauma through inhibition of TLR4/NF-κB signaling pathway. Med Sci Monit. 2016;22:284–288. [PMC free article] [PubMed] [Google Scholar]
41. Camporesi EM, Bosco G. Hyperbaric oxygen pretreatment and preconditioning. Undersea Hyperb Med. 2014;41:259–263. [PubMed] [Google Scholar]
42. Gao ZX, Rao J, Li YH. Hyperbaric oxygen preconditioning improves postoperative cognitive dysfunction by reducing oxidant stress and inflammation. Neural Regen Res. 2017;12:329–336. [PMC free article] [PubMed] [Google Scholar]
Articles from Medical Gas Research are provided here courtesy of Wolters Kluwer -- Medknow Publications
